Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by MisterBon Dec 29, 2009 9:22am
481 Views
Post# 16622247

RE: RE: RE: Resverlogix Announces $5 Million Finan

RE: RE: RE: Resverlogix Announces $5 Million FinanWow, Pahfoh, you must be bitter and must have bought a while ago at a much higher price than it is today. You have a little bitterness in you, eh? That makes me laugh - people on message boards attacking others. Get a life.

True, I was intending to only buy 3k, and ended up getting 2k. So, yeah, $4800.00. For a very spec stock in my RSP/TFSA, I consider that a wise play, but I won't "invest" in a company that uses YA until I see how they use YA, so I took my 10% profit. No one went broke taking a profit - so consider this capital preservation. You should actually do some research on them before you spout your uneducated, vitriol around here. Check out the SEC issues with YA, "Cobalis vs. YA" (in case the link below does not work), etc.

As well, go read the KTV.V board. That should shut you up as far as your other comments - and you'll see why I am LMFA of at you.

https://law.lexisnexis.com/practiceareas/New-Lawsuit-Filings/Litigation-Center---New-Lawsuit-Filings/Cobalis-Corp-Confirms-Filing-Of-5-Count-Lawsuit-Against-Yorkville-AdvisorsYA-Global-Investments


Thats all for now, I'll be watching... Good luck longs, but watch how YA is used.

Bullboard Posts